• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

Nifekalant Hydrochloride

Product ID N3422
Cas No. 130656-51-8
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $88.60 In stock
10 mg $143.10 In stock
25 mg $299.90 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Nifekalant is an antagonist at potassium channels that is clinically used to treat ventricular tachyarrhythmia; it is a class III anti-arrhythmic that increases the time course of myocardial repolarization and may prolong the QT interval. Nifekalant may also be used to treat atrial fibrillation, as it increases right atrial monophasic action potential duration and the atrial effective refractory period in subjects with atrial fibrillation.

Product Info

Cas No.

130656-51-8

Purity

≥98%

Formula

C19H27N5O5 • HCl

Formula Wt.

441.91

Chemical Name

6-[2-[(N-2-Hydroxyethyl)-3-(4-nitrophenyl)-propyl- amino(ethylamino)-1,3-dimethyl-1H,3H - pyrimidine- 2,4-dione monohydrochloride

IUPAC Name

6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1, 3-dimethylpyrimidine-2,4-dione;hydrochloride

Synonym

MS 551

Appearance

Cream-colored crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

N3422 MSDS PDF

Info Sheet

N3422 Info Sheet PDF

References

Harayama N, Nihei SI, Nagata K, et al. Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. J Anesth. 2014 Jan 5. [Epub ahead of print]. PMID: 24389941.

Sonoda K, Watanabe I, Ohkubo K, et al. Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation. Int Heart J. 2013;54(5):279-84. PMID: 24097216.

Pantazopoulos IN, Troupis GT, Pantazopoulos CN, et al. Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias. World J Cardiol. 2011 Jun 26;3(6):169-76. PMID: 21772943.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only